ANI Pharmaceuticals, Inc. operates as a biopharmaceutical firm, concentrating on the development, production, and commercialization of both proprietary (branded) and unbranded (generic) prescription medications across the United States and Canada. The company's primary focus areas include manufacturing controlled substances, treatments for oncology, hormones and steroids, injectable drugs, and various other pharmaceutical preparations. Its robust manufacturing capabilities encompass a range of dosage forms, such as oral solid products, semi-solids, liquid formulations, and topical agents, as well as highly potent compounds. Furthermore, ANI Pharmaceuticals provides contract development and manufacturing services to other pharmaceutical enterprises. The company distributes its products through a diverse network, which includes retail pharmacy chains, wholesalers, distributors, mail-order pharmacies, and group purchasing organizations. Incorporated in 2001, its corporate headquarters are situated in Baudette, Minnesota.
zacks.comHere's Why ANI Pharmaceuticals (ANIP) is a Strong Growth Stockzacks.comJun 16
zacks.comShould You Buy ANI Pharmaceuticals at 9.8x Forward Earnings?zacks.comJun 10
zacks.comANI Pharmaceuticals Targets Acute Gout With Cortrophin Pushzacks.comJun 10
zacks.comANIP Pharmaceuticals' Cortrophin Gel Drives 2026 Growthzacks.comJun 10
zacks.comWhy ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Termzacks.comMay 29